Compare ETON & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ETON | VINP |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 689.8M | 753.0M |
| IPO Year | 2018 | 2020 |
| Metric | ETON | VINP |
|---|---|---|
| Price | $30.29 | $10.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $39.33 | $14.00 |
| AVG Volume (30 Days) | ★ 343.5K | 81.4K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 5.72% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $79,950,000.00 | N/A |
| Revenue This Year | $40.90 | $18.07 |
| Revenue Next Year | $47.23 | $12.74 |
| P/E Ratio | ★ N/A | $24.41 |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $13.09 | $9.20 |
| 52 Week High | $32.31 | $13.61 |
| Indicator | ETON | VINP |
|---|---|---|
| Relative Strength Index (RSI) | 66.74 | 43.54 |
| Support Level | $16.17 | $10.56 |
| Resistance Level | $32.31 | $10.75 |
| Average True Range (ATR) | 1.54 | 0.49 |
| MACD | 0.26 | -0.04 |
| Stochastic Oscillator | 79.33 | 33.44 |
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.